Inception Return
(5/1/2017)
|
6.66 %
|
|
YTD Return
|
9.82 %
|
|
NAVPS
(4/23/2024)
|
$12.88
|
|
Change
|
$0.12 / 0.93 %
|
|
|
Growth of $10,000
(As of March 31, 2024)
|
|
MER
|
0.24 %
|
|
Assets ($mil)
|
$147.19
|
|
Rank (1Yr)
|
91/177
|
|
Std Dev (3Yr)
|
16.69 %
|
|
Volatility Ranking (3Yr)
|
5/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
This fund’s objective is to obtain maximum long-term capital growth. It invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry. This includes companies that provide goods and services to these companies and companies that the portfolio adviser believes would benefit from developments in the health sciences industry.
|
Fund Manager
CI Global Asset Management
Portfolio Manager
Peter Hofstra, CI Global Asset Management
Kevin McSweeney, CI Global Asset Management
Greg Quickmre, CI Global Asset Management
Sub-Advisor
Data not available
|
|
Asset Allocation
(As of March 31, 2024)
|
Sector Allocation
(As of March 31, 2024)
|
Geographic Allocation
(As of March 31, 2024)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Eli Lilly and Co | US Equity | Healthcare | United States | 10.16% |
| UnitedHealth Group Inc | US Equity | Healthcare | United States | 9.63% |
| Novo Nordisk A/S Cl B | International Equity | Healthcare | European Union | 7.72% |
| Humana Inc | US Equity | Healthcare | United States | 7.01% |
| Merck & Co Inc | US Equity | Healthcare | United States | 5.31% |
| AstraZeneca PLC | International Equity | Healthcare | European Union | 4.81% |
| Abbvie Inc | US Equity | Healthcare | United States | 4.19% |
| Zoetis Inc Cl A | US Equity | Healthcare | United States | 3.92% |
| Anthem Inc | US Equity | Healthcare | United States | 3.14% |
| Siemens Healthineers AG | International Equity | Healthcare | European Union | 3.13% |
Performance Data
(As of March 31, 2024)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
1.16
|
9.82
|
12.80
|
9.82
|
16.48
|
3.95
|
6.79
|
-
|
|
Benchmark
|
4.14
|
6.62
|
15.26
|
6.62
|
13.96
|
9.11
|
9.96
|
7.67
|
|
Quartile Ranking
|
3
|
2
|
3
|
2
|
3
|
3
|
3
|
-
|
|
Calendar Return (%)
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
|
Fund
|
4.82
|
0.92
|
2.02
|
13.58
|
14.38
|
3.33
|
-
|
-
|
-
|
-
|
|
Benchmark
|
11.75
|
-5.84
|
25.09
|
5.60
|
22.88
|
-8.89
|
9.10
|
21.08
|
-8.32
|
10.55
|
|
Quartile Ranking
|
3
|
1
|
4
|
3
|
4
|
2
|
-
|
-
|
-
|
-
|